← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

▼ SELL 10b5-1 Plan

$ Value

$858K

Shares

25,756

Price

$33

Filed

May 20

Insider

Name

Kumar Neil

Title

Chief Executive Officer

CIK

0001742485

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

217,804

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 64,696 shares of Common Stock underlying the Reporting Person's RSUs. | This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024. | Represents the weighted average sale price of the shares sold from $32.72 to $33.71 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $33.72 to $33.79 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $33.02 to $33.66 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. | The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. | The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. | The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

Filing Info

Accession No.

0000950170-25-075425

Form Type

4

Issuer CIK

0001743881

Kumar Neil's History

Date Ticker Type Value
2026-04-10 BBIO $1.5M
2026-04-10 BBIO $1.5M
2026-04-09 BBIO $530K
2026-04-09 BBIO $395K
2026-04-09 BBIO $567K
2026-04-09 BBIO $521K
2026-04-09 BBIO $382K
2026-04-09 BBIO $589K
2026-03-27 MAZE A $0
2025-10-09 BBIO $1.1M

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10